280 related articles for article (PubMed ID: 18721488)
1. Mutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2.
Felekkis KN; Koupepidou P; Kastanos E; Witzgall R; Bai CX; Li L; Tsiokas L; Gretz N; Deltas C
BMC Nephrol; 2008 Aug; 9():10. PubMed ID: 18721488
[TBL] [Abstract][Full Text] [Related]
2. Polycystin-2 regulates proliferation and branching morphogenesis in kidney epithelial cells.
Grimm DH; Karihaloo A; Cai Y; Somlo S; Cantley LG; Caplan MJ
J Biol Chem; 2006 Jan; 281(1):137-44. PubMed ID: 16278216
[TBL] [Abstract][Full Text] [Related]
3. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
4. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2.
Bhunia AK; Piontek K; Boletta A; Liu L; Qian F; Xu PN; Germino FJ; Germino GG
Cell; 2002 Apr; 109(2):157-68. PubMed ID: 12007403
[TBL] [Abstract][Full Text] [Related]
5. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
6. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.
Park JY; Schutzer WE; Lindsley JN; Bagby SP; Oyama TT; Anderson S; Weiss RH
BMC Nephrol; 2007 Aug; 8():12. PubMed ID: 17714589
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
[TBL] [Abstract][Full Text] [Related]
8. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.
Aguiari G; Banzi M; Gessi S; Cai Y; Zeggio E; Manzati E; Piva R; Lambertini E; Ferrari L; Peters DJ; Lanza F; Harris PC; Borea PA; Somlo S; Del Senno L
FASEB J; 2004 May; 18(7):884-6. PubMed ID: 15001556
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
12. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
[TBL] [Abstract][Full Text] [Related]
13. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
14. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.
Arnould T; Sellin L; Benzing T; Tsiokas L; Cohen HT; Kim E; Walz G
Mol Cell Biol; 1999 May; 19(5):3423-34. PubMed ID: 10207066
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
Harris PC
Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.
Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954
[TBL] [Abstract][Full Text] [Related]
17. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
[TBL] [Abstract][Full Text] [Related]
18. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of autosomal dominant polycystic kidney disease.
Al-Bhalal L; Akhtar M
Adv Anat Pathol; 2005 May; 12(3):126-33. PubMed ID: 15900113
[TBL] [Abstract][Full Text] [Related]
20. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
